GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 181 filers reported holding GW PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $9,000 | -25.0% | 89 | -14.4% | 0.00% | -20.0% |
Q3 2019 | $12,000 | -33.3% | 104 | 0.0% | 0.01% | -37.5% |
Q2 2019 | $18,000 | 0.0% | 104 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $18,000 | +80.0% | 104 | 0.0% | 0.01% | +60.0% |
Q4 2018 | $10,000 | -44.4% | 104 | 0.0% | 0.01% | -28.6% |
Q3 2018 | $18,000 | +20.0% | 104 | 0.0% | 0.01% | +16.7% |
Q2 2018 | $15,000 | +50.0% | 104 | +16.9% | 0.01% | +50.0% |
Q1 2018 | $10,000 | -16.7% | 89 | 0.0% | 0.00% | -20.0% |
Q4 2017 | $12,000 | +33.3% | 89 | 0.0% | 0.01% | +25.0% |
Q3 2017 | $9,000 | 0.0% | 89 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $9,000 | -18.2% | 89 | 0.0% | 0.00% | -20.0% |
Q1 2017 | $11,000 | +10.0% | 89 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $10,000 | -16.7% | 89 | 0.0% | 0.01% | -16.7% |
Q3 2016 | $12,000 | +50.0% | 89 | 0.0% | 0.01% | +20.0% |
Q2 2016 | $8,000 | +33.3% | 89 | 0.0% | 0.01% | +66.7% |
Q1 2016 | $6,000 | 0.0% | 89 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $6,000 | -25.0% | 89 | 0.0% | 0.00% | -25.0% |
Q3 2015 | $8,000 | – | 89 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |